Copyright Reports & Markets. All rights reserved.

Global GMP Biologics Market Growth (Status and Outlook) 2019-2024

Buy now

Table of Contents

    2019-2024 Global GMP Biologics Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global GMP Biologics Market Size 2014-2024
        • 2.1.2 GMP Biologics Market Size CAGR by Region
      • 2.2 GMP Biologics Segment by Type
        • 2.2.1 Monoclonal Antibodies
        • 2.2.2 Polyclonal Antibody
      • 2.3 GMP Biologics Market Size by Type
        • 2.3.1 Global GMP Biologics Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global GMP Biologics Market Size Growth Rate by Type (2014-2019)
      • 2.4 GMP Biologics Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
        • 2.4.3 Others
      • 2.5 GMP Biologics Market Size by Application
        • 2.5.1 Global GMP Biologics Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global GMP Biologics Market Size Growth Rate by Application (2014-2019)

      3 Global GMP Biologics by Players

      • 3.1 Global GMP Biologics Market Size Market Share by Players
        • 3.1.1 Global GMP Biologics Market Size by Players (2017-2019)
        • 3.1.2 Global GMP Biologics Market Size Market Share by Players (2017-2019)
      • 3.2 Global GMP Biologics Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 GMP Biologics by Regions

      • 4.1 GMP Biologics Market Size by Regions
      • 4.2 Americas GMP Biologics Market Size Growth
      • 4.3 APAC GMP Biologics Market Size Growth
      • 4.4 Europe GMP Biologics Market Size Growth
      • 4.5 Middle East & Africa GMP Biologics Market Size Growth

      5 Americas

      • 5.1 Americas GMP Biologics Market Size by Countries
      • 5.2 Americas GMP Biologics Market Size by Type
      • 5.3 Americas GMP Biologics Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC GMP Biologics Market Size by Countries
      • 6.2 APAC GMP Biologics Market Size by Type
      • 6.3 APAC GMP Biologics Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe GMP Biologics by Countries
      • 7.2 Europe GMP Biologics Market Size by Type
      • 7.3 Europe GMP Biologics Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa GMP Biologics by Countries
      • 8.2 Middle East & Africa GMP Biologics Market Size by Type
      • 8.3 Middle East & Africa GMP Biologics Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global GMP Biologics Market Forecast

      • 10.1 Global GMP Biologics Market Size Forecast (2019-2024)
      • 10.2 Global GMP Biologics Forecast by Regions
        • 10.2.1 Global GMP Biologics Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global GMP Biologics Forecast by Type
      • 10.8 Global GMP Biologics Forecast by Application

      11 Key Players Analysis

      • 11.1 Creative Diagnostics
        • 11.1.1 Company Details
        • 11.1.2 GMP Biologics Product Offered
        • 11.1.3 Creative Diagnostics GMP Biologics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Creative Diagnostics News
      • 11.2 Fisher Bioservices(Thermo Fisher Scientific)
        • 11.2.1 Company Details
        • 11.2.2 GMP Biologics Product Offered
        • 11.2.3 Fisher Bioservices(Thermo Fisher Scientific) GMP Biologics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Fisher Bioservices(Thermo Fisher Scientific) News
      • 11.3 Polpharma Biologics
        • 11.3.1 Company Details
        • 11.3.2 GMP Biologics Product Offered
        • 11.3.3 Polpharma Biologics GMP Biologics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Polpharma Biologics News
      • 11.4 Intertek
        • 11.4.1 Company Details
        • 11.4.2 GMP Biologics Product Offered
        • 11.4.3 Intertek GMP Biologics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Intertek News
      • 11.5 HemaCare
        • 11.5.1 Company Details
        • 11.5.2 GMP Biologics Product Offered
        • 11.5.3 HemaCare GMP Biologics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 HemaCare News
      • 11.6 AGC
        • 11.6.1 Company Details
        • 11.6.2 GMP Biologics Product Offered
        • 11.6.3 AGC GMP Biologics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 AGC News

      ...

        12 Research Findings and Conclusion

        According to this study, over the next five years the GMP Biologics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in GMP Biologics business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares and growth opportunities of GMP Biologics market by product type, application, key companies and key regions.

        This study considers the GMP Biologics value generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
        Monoclonal Antibodies
        Polyclonal Antibody
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
        Hospitals
        Clinics
        Others

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Creative Diagnostics
        Fisher Bioservices(Thermo Fisher Scientific)
        Polpharma Biologics
        Intertek
        HemaCare
        AGC
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global GMP Biologics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of GMP Biologics market by identifying its various subsegments.
        Focuses on the key global GMP Biologics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the GMP Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the size of GMP Biologics submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now